M.O. Christen

943 total citations
32 papers, 819 citations indexed

About

M.O. Christen is a scholar working on Molecular Biology, Organic Chemistry and Biochemistry. According to data from OpenAlex, M.O. Christen has authored 32 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Biochemistry. Recurrent topics in M.O. Christen's work include Ion channel regulation and function (5 papers), Gastrointestinal motility and disorders (4 papers) and Ion Channels and Receptors (4 papers). M.O. Christen is often cited by papers focused on Ion channel regulation and function (5 papers), Gastrointestinal motility and disorders (4 papers) and Ion Channels and Receptors (4 papers). M.O. Christen collaborates with scholars based in France, Belgium and United States. M.O. Christen's co-authors include S. G. Schäfer, Paul Ernsberger, R.W. Frei, Reinhard Kuhn, Patrice Rat, C. Debbasch, Jean‐Pierre Ollivier, Jean‐Louis Burgot, J.M. Scherrmann and Christine Feinle and has published in prestigious journals such as Gastroenterology, Analytical Biochemistry and Annals of the New York Academy of Sciences.

In The Last Decade

M.O. Christen

32 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.O. Christen France 15 327 185 139 136 84 32 819
Bengt‐Arne Persson Sweden 21 216 0.7× 88 0.5× 104 0.7× 120 0.9× 182 2.2× 37 1.4k
B. Norlander Sweden 23 168 0.5× 83 0.4× 161 1.2× 77 0.6× 281 3.3× 53 1.1k
Toru Obata Japan 19 291 0.9× 71 0.4× 127 0.9× 87 0.6× 230 2.7× 62 984
Fusako Takayama Japan 21 280 0.9× 206 1.1× 318 2.3× 89 0.7× 54 0.6× 65 1.2k
John G. Page United States 21 532 1.6× 96 0.5× 111 0.8× 95 0.7× 152 1.8× 43 1.7k
Yoshiro Okano Japan 19 332 1.0× 182 1.0× 131 0.9× 23 0.2× 90 1.1× 87 1.2k
Pascal Champéroux France 18 333 1.0× 104 0.6× 153 1.1× 344 2.5× 37 0.4× 53 904
Hisakuni Hashimoto Japan 19 384 1.2× 161 0.9× 125 0.9× 359 2.6× 114 1.4× 94 1.0k
Brodie Bb 12 389 1.2× 161 0.9× 157 1.1× 93 0.7× 172 2.0× 19 1.4k
S Harigaya United States 16 696 2.1× 127 0.7× 138 1.0× 442 3.3× 95 1.1× 49 1.2k

Countries citing papers authored by M.O. Christen

Since Specialization
Citations

This map shows the geographic impact of M.O. Christen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.O. Christen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.O. Christen more than expected).

Fields of papers citing papers by M.O. Christen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.O. Christen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.O. Christen. The network helps show where M.O. Christen may publish in the future.

Co-authorship network of co-authors of M.O. Christen

This figure shows the co-authorship network connecting the top 25 collaborators of M.O. Christen. A scholar is included among the top collaborators of M.O. Christen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.O. Christen. M.O. Christen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Christen, M.O., Maamed Mademilov, Laura Mayer, et al.. (2025). Electrocardiographic signs of cardiac ischemia at rest and during exercise in patients with COPD traveling to 3,100 m: data from a randomized trial of acetazolamide. Frontiers in Cardiovascular Medicine. 12. 1524201–1524201. 1 indexed citations
2.
Christen, M.O., et al.. (2004). L’anethole dithiolethione : un agent cytoprotecteur contre la ténotoxicité induite par les fluoroquinolones. Pathologie Biologie. 52(6). 308–313. 11 indexed citations
3.
Feinle, Christine, M.O. Christen, David Grundy, et al.. (2002). Effects of duodenal fat, protein or mixed‐nutrient infusions on epigastric sensations during sustained gastric distension in healthy humans. Neurogastroenterology & Motility. 14(2). 205–213. 59 indexed citations
4.
Magous, Richard, et al.. (2001). Contraction of human colonic circular smooth muscle cells is inhibited by the calcium channel blocker pinaverium bromide. Cell Calcium. 29(6). 429–438. 19 indexed citations
5.
Debbasch, C., et al.. (1999). Tacrine-induced Reactive Oxygen Species in a Human Liver Cell Line: The Role of Anethole Dithiolethione as a Scavenger. Toxicology in Vitro. 13(4-5). 683–688. 99 indexed citations
6.
Malysz, John, Laura Farraway, M.O. Christen, & J D Huizinga. (1997). Pinaverium acts as L-type calcium channel blocker on smooth muscle of colon. Canadian Journal of Physiology and Pharmacology. 75(8). 969–975. 10 indexed citations
7.
Bóna, M., et al.. (1995). Water/n‐Octanol Partition Coefficients of 1,2‐Dithiole‐3‐thiones. Journal of Pharmaceutical Sciences. 84(9). 1107–1112. 22 indexed citations
8.
Schäfer, S. G., et al.. (1995). Why Imidazoline Receptor Modulator in the Treatment of Hypertension?. Annals of the New York Academy of Sciences. 763(1). 659–672. 20 indexed citations
9.
Ernsberger, Paul, et al.. (1994). A novel mechanism of action for hypertension control: Moxonidine as a selective I1-imidazoline agonist. Cardiovascular Drugs and Therapy. 8(S1). 27–41. 55 indexed citations
11.
Kuhn, Reinhard, R.W. Frei, & M.O. Christen. (1994). Use of Capillary Affinity Electrophoresis for the Determination of Lectin-Sugar Interactions. Analytical Biochemistry. 218(1). 131–135. 72 indexed citations
12.
Ernsberger, Paul, et al.. (1993). Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.. Journal of Pharmacology and Experimental Therapeutics. 264(1). 172–182. 222 indexed citations
13.
Paillet, Matthieu, et al.. (1990). Rapid determination of xipamide in human plasma and urine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 533. 275–281. 13 indexed citations
14.
Beech, David J., Ian C. Mackenzie, T. B. Bolton, & M.O. Christen. (1990). Effects of pinaverium on voltage‐activated calcium channel currents of single smooth muscle cells isolated from the longitudinal muscle of the rabbit jejunum. British Journal of Pharmacology. 99(2). 374–378. 18 indexed citations
15.
Christen, M.O., et al.. (1989). Protective Effect of Anethol Dithiolthione Against Acetaminophen Hepatotoxicity in Mice. Pharmacology & Toxicology. 65(1). 63–64. 18 indexed citations
16.
DeFeudis, F.V. & M.O. Christen. (1989). State- and use-independent Ca2+ antagonists offer hope in control of GI disorders. Trends in Pharmacological Sciences. 10(5). 170–172. 5 indexed citations
17.
Warnet, Jean‐Michel, et al.. (1989). Study of Glutathione and Glutathione Related Enzymes in Acetaminophen-Poisoned Mice. Prevention by Anethole Trithione Pretreatment. Archives of toxicology. Supplement. 13. 322–325. 5 indexed citations
18.
Borchers, Friedrich, et al.. (1989). Metabolism of isobutylnaphthyl acetic acid in rats: determination of the chemical structures of metabolites. European Journal of Drug Metabolism and Pharmacokinetics. 14(1). 29–34. 1 indexed citations
19.
Christen, M.O., et al.. (1989). Pharmacokinetics and metabolism of14C isobytylnaphtyl acetic acid in rat. European Journal of Drug Metabolism and Pharmacokinetics. 14(4). 249–256. 1 indexed citations
20.
Scherrmann, J.M., et al.. (1989). Pharmacokinetics / bioavailability of colchicine in healthy male volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 14(4). 317–322. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026